State Street
EPIX

State Street’s ESSA Pharma EPIX Stock Holding History

State Street’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-24,414
Closed -$65.9K – 4572
2023
Q2 		$65.9K Sell
24,414
-438
-2% -$1.28K ﹤0.01% 4340
2023
Q1 		$73.8K Sell
24,852
-109
-0.4% -$320 ﹤0.01% 4407
2022
Q4 		$62.9K Buy
24,961
+110
+0.4% +$316 ﹤0.01% 4502
2022
Q3 		$45K Sell
24,851
-5,860
-19% -$15.4K ﹤0.01% 4678
2022
Q2 		$97K Sell
30,711
-33,839
-52% -$189K ﹤0.01% 4551
2022
Q1 		$399K Buy
64,550
+700
+1% +$6.15K ﹤0.01% 4134
2021
Q4 		$907K Buy
63,850
+30,440
+91% +$339K ﹤0.01% 3837
2021
Q3 		$267K Buy
+33,410
New +$531K ﹤0.01% 4245

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return